AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 12, 2024 16:03 ET
|
AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
November 12, 2024 07:29 ET
|
BioStem Technologies, Inc.
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
October 29, 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All MAC Regions
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
October 28, 2024 13:58 ET
|
BioStem Technologies, Inc.
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
RedDress Announces ActiGraft Pro Added to WCA Formulary
October 24, 2024 08:40 ET
|
RedDress
RedDress today announced that ActiGraft Pro has been added to the Wound Care Advantage (WCA) Formulary after a comprehensive evaluation.
Wound Care Market to Witness 3.1% CAGR by 2031 | SkyQuest Technology
October 17, 2024 17:00 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Wound Care Market will attain the value of USD 16.32 Billion by 2031, with a CAGR of 3.1% during the forecast period...
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment
October 17, 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
October 15, 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
October 02, 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft
October 01, 2024 08:37 ET
|
Merakris Therapeutics
Merakris to showcase Lyophilized Amnion Chorion, Dermacyte AC Matrix, at the Fall Symposium for Advanced Wound Care (SAWC) in Las Vegas on October 2-5.